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A B S T R A C T
Understanding factors associated with diﬀerent types of cancer screening non-participation will help with the
development of more targeted approaches for improving informed uptake. This study explored patterns of
general health beliefs and behaviour, and cancer-speciﬁc beliefs across diﬀerent types of cervical screening non-
participants using the Precaution Adoption Process Model (PAPM). A population-representative sample of
women in Britain completed a home-based survey in 2016. Women classiﬁed as non-participants (n=839)
completed additional questions about health beliefs.
Some general health beliefs and behaviours, as well as cancer-speciﬁc beliefs, were associated with particular
types of non-participation. For example, those who scored higher on fatalism were more likely to be unaware of
screening (OR=1.74, 95%CI: 1.45–2.08) or unengaged with screening (OR=1.57, CI: 1.11–2.21). Women with
greater deliberative risk perceptions were less likely to be unengaged with screening (OR=0.74 CI: 02.55–0.99)
and less likely to have decided against screening (OR=0.71, CI: 0.59–0.86). Women who had seen a general
practitioner in the last 12months were less likely to be unaware (OR=0.49, CI: 0.35–0.69), and those reporting
cancer information avoidance were more likely to be unengaged with screening (OR=2.25, CI: 1.15–4.39). Not
wanting to know whether one has cancer was the only factor associated with all types of non-participation.
Interventions to raise awareness of screening should include messages that address fatalistic and negative
beliefs about cancer. Interventions for women who have decided not to be screened could usefully include
messages to ensure the risk of cervical cancer and the relevance and beneﬁts of screening are well commu-
nicated.
1. Introduction
Cancer screening involves testing for higher risk of asymptomatic
early stage cancer or precancerous lesions, which can then be diagnosed
and treated before cancer develops. Population-based screening for
colorectal, breast, and cervical cancer, along with oral cancer screening
for at-risk groups, is recommended by the World Health Organization
(WHO, 2013). Key to the success of all cancer screening is participation
of the asymptomatic, healthy individual, but uptake of cancer screening
is considered sub-optimal across diﬀerent cancers and diﬀerent delivery
systems (NHS Digital, 2016; von Wagner et al., 2011; White et al.,
2017).
Interventions to improve overall uptake of cancer screening have
had limited success (Everett et al., 2011; Wardle et al., 2016) and
support has been growing for a move from ‘one-size-ﬁts-all’ interven-
tions to more tailored or targeted approaches (Kreuter and Wray, 2003;
Myers et al., 2007; Sohl and Moyer, 2007). There has also been a shift in
focus towards improving informed choice in cancer screening, ensuring
that individuals have a good understanding of the risks and beneﬁts
before deciding about participation (Entwistle et al., 2008). Histori-
cally, most models of health behaviour (Ajzen and Fishbein, 1980;
Maddux and Rogers, 1983; Rosenstock, 1966) have suggested a single
set of variables could predict whether a person participates in a health
behaviour (Weinstein, 1988). While these models seem to do a good job
at predicting how those who are aware of a health threat form a deci-
sion about a related behaviour, they oﬀer less insight into the processes
involved for those who are unaware of the threat or those who need to
translate their intentions into action (Weinstein et al., 2008). Conse-
quently, Weinstein proposed the Precaution Adoption Process Model
(PAPM) (Weinstein, 1988) as a way of highlighting diﬀerent stages of
participation (or non-participation) in a health behaviour. The PAPM
describes how for any ‘hazard’ there will be several ‘stages’ through
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which people move before participating in a behaviour to reduce that
hazard. They may be unaware (stage 1: unaware), following which they
may remain unengaged (stage 2: unengaged). There may then be a
period that includes being undecided about whether to participate
(stage 3: undecided), before forming an intention or plan (stage 5:
decided to act), and then translating this into behaviour (stage 6:
acting). A decision not to act can also be made (stage 4: decided not to
act). For ongoing behaviours there is also a stage relating to whether
the behaviour is being continued (stage 7: maintained). Weinstein
proposed that there are qualitative diﬀerences between people at dif-
ferent stages and suggested that understanding the variables relevant to
each stage could contribute to the design of more eﬀective interven-
tions. Initially developed to explain radon testing behaviour, the PAPM
has since been applied to a range of behaviours including osteoporosis
prevention and smoking cessation (reviewed here (Weinstein et al.,
2008)), and more recently to cancer screening (Costanza et al., 2005;
Ferrer et al., 2011; Hester et al., 2015; Marlow et al., 2017).
The PAPM is well suited to cancer screening behaviour because it
draws together a range of empirical ﬁndings, including the fact that
many people who are eligible for screening are unaware or unengaged
(Robb et al., 2010) and that there is a signiﬁcant gap between intention
to be screened and participation in screening (Sheeran, 2002). It also
allows a dedicated space for those who have made a choice not to
participate and therefore works well with the move towards encoura-
ging informed choice in the context of cancer screening (Entwistle
et al., 2008). While the term ‘stage’ is used to highlight the phases
people move through, the PAPM diﬀers from earlier stage models (e.g.
Prochaska and Velicer, 1997) by accepting that there is no set duration
for each ‘stage’ and that people may skip stages or may move back into
earlier stages. These assumptions work well within the cancer screening
context, where the behaviour is repeated every few years, and move-
ment between ‘stages’ before, after and between screening rounds
(backwards and forwards) may occur. This provision allows for deci-
sions about participation to change throughout the period over which
an individual is eligible for screening. For a more detailed description of
how each stage might be applied to cancer screening behaviour see
Marlow et al. (2017).
A basic premise of the PAPM is that there are common barriers
among people in the same stage and that barriers diﬀer between stages.
A number of studies have found support for this in the context of col-
orectal cancer screening. For example, social cognition variables (per-
ceived risk, worry and regret) are better at explaining intention to be
screened, whereas factors relating to life diﬃculty are better at pre-
dicting whether this intention was translated into action (Power et al.,
2008). More speciﬁcally, those who are unaware or unengaged with
colorectal cancer screening are less likely to have seen a health pro-
fessional recently and have poorer self-rated health (Costanza et al.,
2005). Moreover, the unaware are more fatalistic (Costanza et al.,
2005), the unengaged are less worried and report lower perceived risk
(Costanza et al., 2005; Ferrer et al., 2011), and those who have decided
to be screened have higher self-eﬃcacy scores and a greater correlation
between risk perceptions and worry (Hester et al., 2015). These studies
suggest that the PAPM provides a useful framework for considering
diﬀerent types of non-participant at colorectal screening and under-
standing diﬀerences in health beliefs between types of non-participant.
The PAPM has not been applied to cervical screening before and
therefore in the current study we further the application of the PAPM to
cervical screening and i) explore the pattern of health beliefs across
types of non-participant and ii) consider the contribution that diﬀerent
general health beliefs and behaviours, and cancer-speciﬁc beliefs, can
make in explaining an individual's non-participant type. Since this
survey was cross-sectional we have described diﬀerent ‘types’ of non-
participant, rather than referring to stages. We did not form any hy-
potheses since no studies had explored diﬀerences between PAPM
stages in the context of cervical screening or in a country outside of the
US with free universal healthcare.
2. Methods
2.1. Participants
In the UK, women aged 25–64 years receive invitations for cervical
screening every 3 or 5 years. We commissioned six waves of data col-
lection among screening-eligible women across Great Britain in
January/February 2016. Fieldwork was outsourced to a market re-
search agency (TNS) as part of an omnibus survey (i.e. where data are
collected during one interview on behalf of multiple clients). Stratiﬁed
random location sampling was used to select sampling points across
Britain. Interviewers knocked on doors at properties in each location,
inviting people to take part. Three doors were left between each in-
terview. At each location, quotas were set for employment status and
presence of children in the household. Response rates are not recorded
by the market research agency. Ethical approval was granted by the
UCL Research Ethics Committee (ref: 7585/001).
Data were collected using face-to-face computer-assisted personal
interviews (CAPI). A series of four questions assessed awareness of
screening, past screening behaviour and future intention to be screened
(Box 1). Women were classiﬁed into one of six stages of participation
(based on Weinstein (Weinstein, 1988)). A detailed explanation of these
questions and a ﬂow-diagram indicating how women were allocated to
each PAPM stage is available elsewhere (see Fig. 2 of Marlow et al.,
2017). The present article focuses on diﬀerences in health perceptions
among women who were classiﬁed as cervical screening non-partici-
pants. Women who were up-to-date with screening and intended to re-
attend were not asked questions about their health perceptions and
were excluded from these analyses. The decision not to include ques-
tions about heath beliefs for all women was cost-based. Findings re-
lating to socio-demographic diﬀerences between the non-participant
types have been published elsewhere (Marlow et al., 2017).
Box 1
1. ‘In the UK, women who are aged between 25 and 64 are invited to participate in the NHS cervical screening program’ followed by ‘Have
you ever heard of cervical screening, also known as the smear test or Pap test?’ This was accompanied by a photograph of a woman being
screened
(Response options: yes/no/don't know)
2. [Those who responded yes to Q1] ‘Have you ever had a cervical screening test?’
(Response options: yes/know/don't know)
3. [Those who responded yes to Q2] ‘When was the last time you had a cervical screening test?
(Response options: within the last 3 years/3–5 years ago/longer than 5 years ago/don't know).
4. [Those who responded yes to Q1] ‘Do you intend to go when next invited?’
(Response options: yes/no/don't know+ ‘I've never thought about it’ as an additional response for those who had not been screened before)
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2.2. Measures
Women who were classed as cervical screening non-participants
were asked questions assessing their general health beliefs and beha-
viours and cancer-speciﬁc beliefs. Items were selected to cover a range
of aspects previously shown to be associated with general health out-
comes and cancer screening behaviours (see Supplementary Table 1).
Items assessing general health beliefs and behaviours included: GP at-
tendance, self-rated health, trust in the doctor, following of medical
advice, perceived body awareness, general fatalism (i.e. belief that life
events are predestined and beyond the individual's control (Straughan
and Seow, 1998; Powe and Finnie, 2003)), future orientation (the ex-
tent to which one thinks about or considers the future (Strathman et al.,
1994)) and information seeking behaviour. Items assessing cancer-
speciﬁc beliefs included: knowledge of cervical cancer risk factors, fa-
mily history (of cervical cancer), perceived risk, cancer fatalism (i.e.
belief that getting cancer is beyond the individual's control (Powe and
Finnie, 2003)), belief that cancer is a death sentence, not wanting to
know about having cancer and cancer information avoidance. Women
who had heard of and engaged with cervical screening were also asked
about their knowledge and beliefs about cervical screening. As we were
interested in understanding women's existing beliefs, those who had
never heard of or thought about cervical screening (unaware/un-
engaged women) were not asked these questions.
2.2.1. Socio-demographic characteristics
Age and marital status were assessed using items designed by TNS
or based on the 2011 census. Social grade represented the occupation of
the Chief Income Earner in the household: AB managerial/professional;
C1 supervisory; C2 skilled manual; D semi-skilled/unskilled manual; E
casual/lowest grade workers (Ipsos, 2009). Ethnicity was assessed using
the question from the 2011 census (ONS, 2011).
2.3. Analysis
Women were excluded if they reported having had a hysterectomy
or cervical cancer (n=369), were over 60 years old and living in
Scotland (n=27; cervical screening stops at 60 years in Scotland) or
provided insuﬃcient data to determine their screening status
(n=152). ANOVA and chi-squares were used to explore overall mean/
proportion diﬀerences across non-participant types. Where overall dif-
ferences were present, logistic regression compared each of the non-
participant types with those who had formed an intention to be
screened (intenders; reference group). Odds Ratios (ORs) and 95%
Conﬁdence Intervals (CI) are reported. Since most variables are con-
tinuous, the OR represents the change in odds of being a particular non-
participant type for each point on the scale (Hosmer et al., 2013).
Multivariate models were run for each non-participant group (re-
lative to the intenders), using a step-wise approach including socio-
demographics, followed by psychological variables (signiﬁcant in uni-
variate analyses). This gave an overall estimate of how much these
variables contributed to explaining each non-participant type. For non-
intenders a third step was included adding attitudes to screening.
3. Results
Of the 3113 women who completed the survey, 855 women were
classiﬁed as screening non-participants. A small number were un-
decided about screening (n=16) and were excluded, leaving 839 for
further analyses. These women were: unaware of screening (n=254),
unengaged with screening (n=41), had decided not to be screened
(n=118) or were intending to be screened but currently overdue
(n=426). Sample characteristics are reported in Table 1. Overall there
were signiﬁcant diﬀerences across the four types of non-participant for
each of the health beliefs, with the exception of cancer knowledge
(Table 2).
3.1. Unaware
In the multinomial logistic regression with those intending to be
screened as the reference group, three of the general health belief and
behaviour items were associated with being unaware of screening
(Table 3). Women who had seen a GP in the 12 last months were less
likely to be unaware of screening (OR=0.49, CI: 0.35–0.69). Those
who scored higher on body awareness were more likely to be unaware
of screening (OR=1.43, CI: 1.19–1.73), as were those with higher
general fatalism (OR=1.74, CI: 1.45–2.08). There were also associa-
tions with several cancer-speciﬁc beliefs. Those with family experience
of cervical cancer were less likely to be unaware of screening
(OR=0.25, CI: 0.14–0.46). Higher cancer fatalism was associated with
greater odds of being unaware (OR=1.31, CI: 1.11–1.55) and asso-
ciations were in the same direction for believing cancer is a death
sentence (OR=1.26, CI: 1.08–1.47) and not wanting to know if one
had cancer (OR=1.56, CI: 1.35–1.80). Alongside socio-demographics,
general health beliefs and behaviour explained around 27% of the
variance in being unaware of screening and this increased to 30% when
the cancer-speciﬁc beliefs were added to the model (Table 4).
3.2. Unengaged
Higher general fatalism was associated with being unengaged
(OR=1.57, CI: 1.11–2.21). In addition, higher future orientation and
information seeking scores were associated with lower odds of being
unengaged (OR=0.65, CI: 0.45–0.96 and OR=0.61, CI: 0.44–0.84
respectively). Among the cancer-speciﬁc items, greater perceived risk
was associated with being less likely to be unengaged (Deliberative:
OR=0.74, CI: 02.55–0.99; Experiential: OR=0.58, CI: 0.42–0.79;
Aﬀective: OR=0.39, CI: 0.23–0.66). In addition, higher scores on
cancer fatalism and not wanting to know if one had cancer were as-
sociated with higher odds of being unengaged (OR=1.49,
CI:1.09–2.04 and OR=1.53, CI:1.19–1.98 respectively). Women who
reported avoiding cancer information were more likely to be unengaged
(OR=2.25, CI: 1.15–4.39). Alongside socio-demographics, general
health beliefs and behaviour explained around 23% of the variance in
being unengaged with screening and this increased to 43% when the
cancer-speciﬁc beliefs were added to the model (Table 4).
Table 1
Sample characteristics of non-participants (n=839).
n %
Age
25–34 336 40.0
35–44 235 28.0
45–54 153 18.2
55–64 115 13.7
Social grade
AB 113 13.5
C1 218 26.0
C2 160 19.1
D 190 22.6
E 158 18.8
Ethnicity
White British/Irish 503 60.0
Any other White 107 12.8
South Asian 121 14.4
Black 70 8.3
Mixed/other ethnicity 32 3.8
Non-participant type
Unaware 254 30.3
Unengaged 41 4.9
Decided not to be screeneda 118 14.1
Intending to be screened 426 50.8
a Including n=34 women who were currently up to date but had decided not to attend
when next invited.
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3.3. Deciding not to be screened
Reporting good/excellent health was associated with lower odds of
deciding not to be screened (OR=0.57, CI: 0.37–0.88). Women who
reported greater trust in the doctor and usually following medical ad-
vice were less likely to have decided not to be screened (OR=0.69, CI:
0.55–0.87 and OR=0.71, CI: 0.58–0.87 respectively) and those with
higher perceived body awareness were more likely to have decided not
to be screened (OR=1.42, CI: 1.12–1.70). Those with greater per-
ceived risk were less likely to have decided against screening
(Deliberative: OR=0.71, CI: 0.59–0.86; Experiential: OR=0.66, CI:
0.54–0.80; Aﬀective: OR=0.62, CI: 0.48–0.79). Not wanting to know
if one had cancer was associated with higher odds of deciding not to be
screened (OR=1.44, CI: 1.21–1.70). Socio-demographics and general
health beliefs and behaviour explained around 29% of the variance in
deciding not to be screened and this increased to 37% when the cancer-
speciﬁc beliefs were added to the model (Table 4).
Higher perceived beneﬁts of cervical screening were associated with
lower likelihood of deciding not to be screened (OR=0.27, CI:
0.19–0.40) and higher perceived barriers were associated with greater
likelihood of deciding against screening (OR=1.50, CI: 1.25–1.80 and
OR= 1.64, CI: 1.33–2.02 for embarrassment and pain respectively).
Table 2
Diﬀerences in health beliefs between types of cervical screening non-participants.
Unaware
(n=254)
Unengaged
(n=41)
Decided not to be screened
(n=118)
Intending to be screened
(n=426)
F, χ2 or t
(p-Value)
Mean (SD) or % (n) Mean (SD) or % (n) Mean (SD) or % (n) Mean (SD) or % (n)
General health beliefs and behaviours
Seen GP in last 12months (% yes) 61.2 (142) 63.4 (26) 73.0 (84) 76.3 (318) 17.86 (< 0.001)
Self-rated health (% good or excellent) 73.9 (156) 80.0 (32) 60.6 (66) 73.0 (300) 8.91 (0.030)
Trust in doctor (range: 1–5) 3.93 (0.77) 3.70 (0.99) 3.55 (1.05) 3.83 (0.76) 5.47 (0.001)
Follow medical advice (range: 1–5) 3.86 (0.82) 3.77 (0.99) 3.44 (1.14) 3.79 (0.95) 5.07 (0.002)
Body awareness (range: 1–5) 3.77 (0.86) 3.65 (1.08) 3.76 (0.81) 3.47 (0.96) 6.41 (< 0.001)
General fatalism (range: 1–5) 3.33 (0.93) 3.24 (1.10) 2.77 (1.08) 2.79 (1.00) 15.55 (< 0.001)
Future orientation (range: 1–5) 3.82 (0.73) 3.47 (1.06) 3.34 (0.94) 3.76 (0.76) 11.15 (< 0.001)
Information seeking (range: 1–5) 3.76 (0.78) 3.23 (1.21) 3.52 (1.07) 3.70 (0.89) 5.02 (0.002)
Cancer-speciﬁc beliefs
Knowledge of cervical cancer risk factors (range: 0–8) 3.29 (2.86) 3.32 (2.60) 3.36 (2.38) 3.54 (2.40) 0.54 (0.654)
Cervical cancer in family (% yes) 5.3 (13) 7.3 (3) 9.6 (11) 18.1 (77) 42.00 (0.001)
Deliberative risk (range: 1–7) 3.37 (1.49) 2.94 (1.64) 2.98 (1.56) 3.57 (1.30) 5.08 (0.002)
Experiential risk (range: 1–5) 2.84 (1.18) 2.13 (0.99) 2.26 (1.17) 2.77 (1.06) 9.34 (< 0.001)
Aﬀective risk (range: 1–5) 1.84 (1.13) 1.29 (0.68) 1.52 (0.97) 1.95 (1.00) 10.92 (< 0.001)
Cancer fatalism (range: 1–5) 3.14 (1.04) 3.29 (1.04) 2.92 (1.08) 2.84 (1.08) 4.72 (0.003)
Cancer is a death sentence (range: 1–5) 3.10 (1.13) 2.80 (1.11) 2.69 (1.16) 2.82 (1.05) 4.18 (0.006)
I would not want to know if I had cancer (range: 1–5) 2.75 (1.18) 2.73 (1.26) 2.62 (1.39) 2.09 (1.15) 16.85 (< 0.001)
Cancer information avoidance (% yes) 18.5 (42) 39.0 (16) 26.3 (30) 22.2 (92) 9.45 (0.024)
Cervical screening beliefs
Beneﬁts of cervical screening (range 1–5) – – 3.72 (0.71) 4.24 (0.57) 8.01 (< 0.001)
Screening is embarrassing (range 1–5) – – 3.47 (1.29) 2.89 (1.18) 4.45 (< 0.001)
Screening is painful (range 1–5) – – 3.27 (1.14) 2.70 (1.04) 4.89 (< 0.001)
Purpose of screening (range 1–5) – – 2.45 (1.22) 2.22 (1.07) 1.89 (0.060)
Cervical screening norms (range 1–11) – – 5.86 (2.10) 6.05 (2.04) 0.83 (0.408)
Data collected in Great Britain in 2016.
Table 3
Predictors of being each non-participant type (univariate ORs and 95% CIs).
Unaware v intending to be screened Unengaged v intending to be screened Decided not to be screened v intending to be
screened
General health beliefs and behaviours
Seen GP in last 12months (B) 0.49 (0.35–0.69) 0.54 (0.27–1.06) 0.84 (0.53–1.35)
Good self-rated health (B) 1.05 (0.72–1.53) 1.48 (0.66–3.31) 0.57 (0.37–0.88)
Trust in doctor 1.16 (0.94–1.44) 0.83 (0.57–1.21) 0.69 (0.55–0.87)
Follow medical advice 1.09 (0.90–1.30) 0.98 (0.69–1.39) 0.71 (0.58–0.87)
Body awareness 1.43 (1.19–1.73) 1.24 (0.87–1.77) 1.42 (1.12–1.80)
General fatalism 1.74 (1.45–2.08) 1.57 (1.11–2.21) 0.98 (0.80–1.21)
Future orientation 1.10 (0.88–1.38) 0.65 (0.45–0.96) 0.56 (0.44–0.71)
Information seeking 1.08 (0.90–1.31) 0.61 (0.44–0.84) 0.81 (0.65–1.02)
Cancer-speciﬁc beliefs
Cervical cancer in family (B) 0.25 (0.14–0.46) 0.36 (0.11–1.19) 0.48 (0.25–0.93)
Deliberative risk 0.90 (0.79–1.03) 0.73 (0.57–0.93) 0.74 (0.64–0.87)
Experiential risk 1.06 (0.91–1.24) 0.58 (0.42–0.79) 0.66 (0.54–0.80)
Aﬀective risk 0.91 (0.77–1.07) 0.39 (0.23–0.66) 0.62 (0.48–0.79)
Cancer fatalism 1.31 (1.11–1.55) 1.49 (1.09–2.04) 1.08 (0.88–13.2)
Cancer is a death sentence 1.26 (1.08–1.47) 0.98 (0.73–1.32) 0.89 (0.73–1.08)
I would not want to know if I had cancer 1.56 (1.35–1.80) 1.53 (1.19–1.98) 1.44 (1.21–1.70)
Cancer information avoidance (B) 0.80 (0.53–1.20) 2.25 (1.15–4.39) 1.25 (0.78–2.02)
Data collected in Great Britain in 2016.
OR=Odds Ratio, CI= conﬁdence interval
Note: since most variables are continuous the OR represents the change in odds of being in the group for each point on the scale (predominantly from 1 to 5). B indicates that the variable
was binary and the OR represents the odds of being in this group.
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Adding these items as an additional step in the multivariate model in-
creased the variance explained to 50%.
4. Discussion
This study applied the PAPM to cervical screening and identiﬁed
unique psychological characteristics of diﬀerent types of screening non-
participant, including those who were unaware and unengaged with
screening as well as those who had made a decision either to be
screened or not to be screened. This is the ﬁrst study to explore dif-
ferences in health beliefs across PAPM types for cervical screening.
Moreover, it is the ﬁrst time the PAPM has been applied to cancer
screening outside of the US, in a context where screening is oﬀered as
part of an organized programme. We found key diﬀerences between
non-participant types suggesting ways in which the content and de-
livery of interventions to increase cervical screening uptake may need
to vary across diﬀerent types. The ﬁndings presented here complement
our paper exploring socio-demographic diﬀerences between non-parti-
cipant types (using the same dataset) (Marlow et al., 2017).
Those who were unaware of screening were the most fatalistic about
cancer prevention and had the most negative attitudes towards cancer,
consistent with previous studies in the context of colorectal cancer
screening (Costanza et al., 2005; Ferrer et al., 2011). The unengaged
women were slightly less fatalistic, but still more so than those in-
tending to be screened. The cross-sectional nature of the survey means
we cannot determine causality; while it may be that these women have
low awareness of screening so do not think there is anything that can be
done to avoid cancer, it is also possible that fatalistic beliefs drive
avoidance of health information and contribute to low awareness of
screening. The associations with general fatalism suggest these beliefs
may preclude awareness, at least to some extent. Highlighting the
availability of screening and communicating positive messages around
cancer prevention may help to reduce fatalism in this group. Since the
current written materials do not seem to be reaching these women and
they are less likely to have seen a GP recently, using alternative chan-
nels (e.g. television or radio campaigns) could be beneﬁcial. One study
showed a video intervention designed to decrease fatalism and increase
knowledge of colorectal cancer was eﬀective (Powe and Weinrich,
1999). Another avenue to consider might be a community-based em-
powerment intervention which would educate, motivate and enable
women, ensuring they have the means and the motivation to access
screening services (Hou and Cao, 2017).
Diﬀerent psychological variables seemed to play a role for women
who had decided not to be screened. Fatalistic beliefs were not asso-
ciated with deciding against screening. Instead these women had lower
cancer risk perceptions, suggesting they did not feel screening was re-
levant to them. In addition, we found that these women were less likely
to trust a doctor or to follow medical advice, perhaps suggesting ne-
gative previous experiences with the healthcare system. Ensuring risk
perceptions are accurate may be important to ensure that women who
have decided not to be screened have made an informed decision.
Addressing negative health perceptions about doctors and medical ad-
vice more generally could also be important for facilitating screening
among these women. Future work might explore these previous nega-
tive experiences. This might lead to improvements in the service for all
women and fewer women deciding not to re-attend.
The unengaged women were similar to the unaware women in some
respects, but similar to those who had decided not to be screened in
others. Higher fatalistic beliefs and lower perceived risk were asso-
ciated with being unengaged. As might be expected, the unengaged
women were less likely to report seeking information about health and
more likely to avoid cancer in the media. This active avoidance means
they will likely be a diﬃcult group to access. Given the relatively small
size of the unengaged type, it is unlikely they will be the primary target
for interventions, but rather they may be “mopped up” by campaigns
aimed at those who are unaware and those who have decided not to
participate.
Age, social grade and ethnicity explained around 20% of the var-
iance for unaware women and those who had decided not to be
screened. This suggests that factors associated with economic condi-
tions and life stage play an important role in understanding some of the
diﬀerent types of screening non-participants. Along with socio-demo-
graphics, general health beliefs and behaviour explained a similar
proportion of the variance for women who were unaware, unengaged
and those who had decided not to be screened (23–29%). Cancer-spe-
ciﬁc beliefs explained a greater proportion of the variance in the un-
engaged and decided not to be screened groups (38% and 32%) than
the unaware group (27%). The overall model for deciding not to be
screened, which included cervical screening attitudes, explained 50% of
the variance, which is similar to previous studies exploring attitudes as
predictors of intention (Armitage and Conner, 2001). The items we
included were predominantly informed by previous research and health
behaviour theories which have not focused on the unaware as a unique
type of non-participant. Future work might explore the role of diﬀerent
variables in earlier PAPM stages, perhaps trait variables such as con-
scientiousness, or scales assessing life diﬃculties and access to social
support.
A better understanding of the socio-demographic and psychological
characteristics of screening non-participants can contribute to more
eﬀective tailoring or targeting of interventions (Kreuter and Skinner,
2000). One option is to use a woman's socio-demographic character-
istics to predict which non-participant type she is most likely to be and
send her intervention materials with appropriate content for that group
(‘targeted’ communication). As technology advances, assessing in-
dividual ‘stage’ of non-participation is likely to become more feasible,
making the tailoring of messages to individual women a more viable
option. For example, smart phone apps are now being used by GP
practices in the UK and this mechanism could be used to ask direct
questions about awareness and behaviour (e.g. using the PAPM algo-
rithm). Women could then be allocated to a particular non-participant
group opening up the opportunity for individually tailored messages.
Table 4
Predictors of being unaware, unengaged and deciding not to get screened.
Unaware Unengaged Decided not to be screened
Model 1: socio-demographics
N 676 466 541
Model X2(df) 117.35 (11) 25.05 (11) 78.85 (11)
R2 (Nagelkerke) 0.21 0.12 0.21
Model 2: general health beliefsa
N 569 412 481
Step X2(df) 17.73 (8) 20.66 (8) 28.69 (8)
Model X2(df) 122.38 (19) 42.80 (19) 100.92 (19)
R2 (Nagelkerke) 0.27 0.23 0.29
Model 3: cancer-speciﬁc beliefsa
N 486 389 448
Step X2(df) 26.15 (7) 44.23 (7) 37.54 (7)
Model X2(df) 99.43 (18) 72.95 (18) 102.35 (18)
R2 (Nagelkerke) 0.27 0.38 0.32
Model 4: general health and cancer-speciﬁc beliefsa
N 458 362 423
Step X2(df) 33.04 (15) 48.58 (15) 52.92 (15)
Model X2 (df) 106.51 (26) 71.28 (26) 116.46 (26)
R2 (Nagelkerke) 0.30 0.43 0.37
Model 5: general health, cancer-speciﬁc and cervical screening beliefsb
N – – 409
Step X2(df) 40.71 (3)
Model X2(df) – – 159.16 (29)
R2 (Nagelkerke) – – 0.50
Data collected in Great Britain in 2016.
Reference group= intending to be screened.
a Socio-demographics (age, social grade and ethnicity) were entered ﬁrst.
b Socio-demographics (age, social grade and ethnicity), general health and cancer-
speciﬁc beliefs were entered ﬁrst.
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4.1. Limitations
There are several imitations to this study. The sample was popula-
tion-representative but there are likely to be some response biases. In
addition, we do not have a response rate and therefore cannot comment
on how generalizable the sample is likely to be. We used self-reported
screening uptake and intention to assess PAPM stage because we did
not have access to medical records. In addition the items assessing
health beliefs were not from a previously validated psychometric tool.
The survey was also cross-sectional, so we cannot be sure of the causal
direction of some of the associations identiﬁed.
Women who were intending to be screened were generally less
fatalistic and less negative about cancer, scoring above the mean on
perceived beneﬁts of cancer screening and below the mean on barriers.
We did not ask questions about health beliefs to women who attended
screening (a cost-based decision), so not all stages of the PAPM are
explored in the survey and while we can comment on diﬀerences be-
tween some types of non-participant, we were not able to explore dif-
ferences in health beliefs between those who intend to be screened and
those who participate.
The PAPM suggests that analysis should consider the diﬀerence
between those who are undecided and those who have decided not to
participate, in parallel with comparisons between the undecided and
the decided to act. These analyses would oﬀer insight into what con-
tributes to progress from being undecided to forming a decision to act
or not. Very few women were undecided about cervical screening so we
were not able to examine the data in this way, but this suggests that if
we can make women aware of screening, many of them will go on to
make a decision.
5. Conclusion
Weinstein et al. describe how the PAPM oﬀers a “skeleton” that
“needs to be ﬂeshed out for each behaviour” (Weinstein et al., 2008).
Here we report the ﬁrst attempt to do this for cervical screening, pro-
viding evidence that health beliefs may vary across diﬀerent types of
non-participant, in line with the PAPM. Our ﬁndings suggest that de-
veloping interventions to raise awareness of screening should include
messages that address fatalistic and negative beliefs about cancer. In
addition, interventions for women who have decided not to be screened
may need to include messages that clearly communicate the risk of
cervical cancer and the relevance and beneﬁts of screening.
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